4th Quarter - Report

CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES

Firm
Client
Income
—
Expenses
$200,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Financial Institutions/Investments/Securities FIN

Support permanent exemption from Section 404(b) of Sarbanes-Oxley Act for smaller reporting companies (HR 4173).

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4173 (111th)

Taxation/Internal Revenue Code TAX

Address concerns with impact of proposed medical device manufacturer fee/tax provision of healthcare reform legislation.

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Oppose provisions in patent reform legislation (HR 1260/S 515) that would undermine certainty and weaken patent rights.

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1260 (111th)

Health Issues HCR

Support science-based pro-innovation pathway for FDA approval of biosimilars/follow-on biologics in healthcare reform legislation. Address concerns with application of comparative effectiveness research and the consequences to biomedical innovation and patient access. Address concerns with impact of proposed medical device manufacturer fee/tax provision of healthcare reform legislation. Address concerns with proposed independent medicare advisory board entities in healthcare reform legislation. Oppose drug importation provision of healthcare reform legislation. Support "Prostate Research, Imaging and Men's Education Act" (S. 756). Support "Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009" (HR 3974)

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3974 (111th), S. 756 (111th)

Medicare/Medicaid MMM

Address concerns with application of comparative effectiveness research and the consequences to biomedical innovation and patient access. Address concerns with proposed independent medicare advisory board entities in healthcare reform legislation.

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Support "Prostate Research, Imaging and Men's Education Act" (S. 756). Support "Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009" (HR 3974).

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 756 (111th), H.R. 3974 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.